
Larimar Therapeutics, Inc.
LRMRNasdaqCIK 1374690HealthcareFiscal year ends Dec 31
Reports and events: 239 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2021-08-1210:28 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001564590-21-043701 |
| 2021-07-0217:08 ET | SC 13D/A | Ownership report, active investor, amended | 0001193805-21-000975 |
| 2021-07-0106:11 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-205474 |
| 2021-06-1417:21 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-190213 |
| 2021-05-2613:48 ET | SC 13D/A | Ownership report, active investor, amended | 0001193805-21-000725 |
| 2021-05-2610:17 ET | 8-K | 1.02 Termination of a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-173167 |
| 2021-05-2117:05 ET | SC 13D/A | Ownership report, active investor, amended | 0001193805-21-000700 |
| 2021-05-2109:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-21-168704 |
| 2021-05-2107:28 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-168548 |
| 2021-05-1815:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-165178 |
| 2021-05-1706:08 ET | 8-K | 5.07 Shareholder vote results | 0001193125-21-162647 |
| 2021-05-1108:34 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-157048 |
| 2021-05-1016:30 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001564590-21-026084 |
| 2021-05-1016:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-156249 |
| 2021-04-1409:08 ET | DEF 14A | Proxy statementPeriod 2021-05-12 | 0001193125-21-115586 |
| 2021-03-0417:16 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001193125-21-069725 |
| 2021-03-0417:09 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001564590-21-011003 |
| 2021-03-0407:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-068478 |
| 2020-12-0807:40 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-312288 |
| 2020-11-1216:51 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001193125-20-291777 |
| 2020-11-1216:41 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001564590-20-053618 |
| 2020-11-1016:23 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-20-290185 |
| 2020-10-3017:02 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-20-282731 |
| 2020-09-2916:39 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-20-257868 |
| 2020-09-2907:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-20-257168 |
| 2020-08-1906:08 ET | DEF 14A | Proxy statementPeriod 2020-09-29 | 0001193125-20-224087 |
| 2020-08-1416:56 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001193125-20-220561 |
| 2020-08-1416:48 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001564590-20-040314 |
| 2020-08-1107:38 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-20-215639 |
| 2020-08-0609:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-20-211426 |
| 2020-07-0116:01 ET | SC 13D/A | Ownership report, active investor, amended | 0001193805-20-000766 |
| 2020-06-3016:46 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-20-184105 |
| 2020-06-2617:08 ET | 8-K/A | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-181113 |
| 2020-06-0817:21 ET | SC 13D | Ownership report, active investor | 0001193125-20-163701 |
| 2020-06-0817:10 ET | SC 13D | Ownership report, active investor | 0001193805-20-000670 |
| 2020-06-0321:27 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-20-158916 |
| 2020-06-0207:49 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-20-157924 |
| 2020-05-0716:38 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001564590-20-022942 |
| 2020-04-2417:01 ET | 8-K | 3.01 Delisting notice | 0001193125-20-119225 |
| 2020-03-0918:09 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-20-065288 |
| 2020-03-0516:31 ET | 10-K | Annual reportPeriod 2019-12-31 | 0001564590-20-008984 |
| 2020-03-0516:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-20-063097 |
| 2020-02-0516:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-20-025413 |
| 2020-01-1307:17 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-005893 |
| 2019-12-2709:25 ET | SC 13D | Ownership report, active investor | 0001193125-19-325057 |
| 2019-12-1808:13 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.01 Change in control; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-19-316828 |
| 2019-11-0616:40 ET | 10-Q | Quarterly reportPeriod 2019-09-30 | 0001564590-19-041090 |
| 2019-11-0616:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-19-285939 |
| 2019-09-1917:00 ET | 8-K | 3.01 Delisting notice | 0001193125-19-249639 |
| 2019-09-1217:19 ET | 8-K | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-19-244019 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 17:49 ET. Listed shows no prices and gives no investment advice.